Dolby Laboratories (DLB) risk factors, FY2025 10-K

Dolby Laboratories's FY2025 10-K, filed Nov 18, 2025. The risk counts for this filing are not shown yet. The filing itself is linked below.

What the changes say

  • No new risks were added this year.
  • The foreign competition-law risk now emphasizes significant disputes, formal regulatory actions, and costly legal proceedings.
  • The technology-trends risk is unchanged, while two licensing-revenue risks were removed.

What changed since the prior 10-K

Dropped

  • Dropped

    Customers and Distributors

    Dependence on OEMs and other licensees to adopt Dolby technologies and sell products.

  • Dropped

    Reporting practices and uncertainty may result in fluctuations in our royalty revenue from period to period

    Royalty-report corrections, retroactive royalties, and licensing revenue timing can cause period-to-period volatility.

Reworded

  • 37% rewritten

    Any or all of these factors, and the uncertainties associated with them, may impact our ability to operate in foreign countries and our ability to develop, the demand for, and profitability of, our technologies and products, as well as our customers' products that incorporate our technologies

    Removed the resolved South Korean investigation example and added risks from significant disputes, formal regulatory actions, costly legal proceedings, and prohibited foreign business practices.

  • 25% rewritten

    TECHNOLOGY TRENDS AND DEVELOPMENTS

    No substantive change; the risk still covers rapid technology change, evolving standards, customer demand, and product obsolescence affecting growth.

Risk factor headings as read

Headings as the filing states them, in filing order.

Other

  1. 01TECHNOLOGY TRENDS AND DEVELOPMENTS25% rewritten
  2. 02LEGAL AND REGULATORY COMPLIANCE
  3. 03Any or all of these factors, and the uncertainties associated with them, may impact our ability to operate in foreign countries and our ability to develop, the demand for, and profitability of, our technologies and products, as well as our customers' products that incorporate our technologies37% rewritten
  4. 04Moreover, the Dolby family and their affiliates may take actions in their own interests that our other stockholders do not view as beneficial

Other Dolby Laboratories 10-Ks

  • FY2024 10-K risk factors
    Risk factors section under review

    Licensing revenue depends on OEM adoption, non-exclusive agreements, and royalty-reporting timing outside Dolby’s control.

    Filed Nov 19, 2024

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.